Skip to content
Mathmarkets
Mathmarkets
  • Home
  • About
  • Company Analysis
  • Industry Analysis
  • Knowledge Bytes
  • Contact
Mathmarkets

Healthcare in India

chintan, November 9, 2024December 25, 2024

Healthcare in India is growing at a significant pace. The healthcare delivery industry in India has reached 5 lakh crore and is poised to grow at 10%-12% across the next decade. Below is how Indian healthcare industry benchmarked with the world standards.

Along with the structural demand existing in the country and the potential opportunity it provides for growth, provision of healthcare in India is still riddled with many challenges. The key challenges are inadequate health infrastructure, unequal quality of services provided based on affordability and healthcare financing.

India lags peers in healthcare expenditure

Global healthcare spending has been rising faster in keeping with the economic growth. As the economy grows, public and private spending on health increases, too. Also, greater sedentary work is giving rise to chronic diseases, which is also pushing up healthcare spending. Fast-growing economies with low spending on health are seeing chronic diseases increase dramatically as they move up the income ladder. Developed economies such as United states, Germany, France, Japan, United Kingdom, spend higher on healthcare as compared to developing nations such as India, Vietnam, Indonesia, etc.

According to the Global Health Expenditure Database compiled by the WHO, in CY2020, India’s expenditure on healthcare was 3.0% of GDP. As of CY2020, India’s healthcare spending as a percentage of GDP trails not just developed countries, such as the US and UK, but also developing countries such as Brazil, Nepal, Vietnam, Singapore, Sri Lanka and Malaysia.

Further, India’s public spending on healthcare services remains much lower than its global peers. For example, India’s per-capita total expenditure on healthcare (at an international dollar rate, adjusted for purchasing power parity) was only $56.6 in CY2020 versus the US’s $11,702.4, the UK’s $4,926.3 and Singapore’s $3,537.0.

India has one of the highest shares of out-of-pocket expenditure in healthcare; however, the government aims to increase public healthcare expenditure to 2.5-3% of GDP by 2025 from the current ~2%, as per the National Health Policy.

The Government of India spends little in healthcare given the size of the economy, which drives the higher out-of-pocket expenditure in India. Despite the decline in the past few years, India’s OOPE as percent of current health spending is 51% as of CY2020, significantly above the average for lower-middle income countries, and amongst the highest in the world. As per economic survey data for FY2021-22, 80-85% of the in-patient hospitalisations did not have any coverage. This explains the higher share of OOPE in health care expenditure. The government of India has introduced schemes such as Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (ABPMJAY), state sponsored health insurance (AB-PMJAY State Extension Schemes), Employees’ State Insurance Scheme (ESIS), Central Government Health Scheme to increase the coverage of medical insurance.

Health infrastructure of India in dire need of improvement

The adequacy of a country’s healthcare infrastructure and personnel is a barometer of its quality of healthcare. India accounts for nearly a fifth of the world’s population, but has an overall bed density of merely 15, with the situation being far worse in rural than urban areas. India’s bed density not only falls far behind the global median of 29 beds, it also lags that of other developing countries such as Brazil (21 beds), Malaysia (19 beds), and Vietnam (26 beds).

As opposed to the decreasing rate in communicable diseases, lifestyle-related illnesses or non-communicable diseases (NCDs) have been increasing rapidly in India over the past few years. The contribution of NCDs to the disease profile rose from 30% in 1990 to 55% in 2016. Recent statistics show these illnesses accounted for nearly 66% of all deaths in India in 2019.

As per the World Economic Forum, the world will lose nearly $30 trillion by 2030 for treatment of NCDs and India’s share of this burden will be $5.4 trillion.

In 2019, of the total disease burden, the contribution of the group of risks (unhealthy diet, high blood pressure, high blood sugar, high cholesterol, and overweight) which mainly cause ischemic heart disease, stroke and diabetes rose to~27%.

Below is the cost of various treatments in India vs various other countries

Industry Analysis Knowledge Bytes Global healthcare industryHealthcare IndiaHealthcare industryHospitalsIndiaNH

Post navigation

Previous post
Next post

Related Posts

Industry Analysis Blue dart vs TCI express

Blue dart express vs TCI express

September 11, 2023September 11, 2023

Blue dart vs TCI express

Read More
Company Analysis Analytics

LatentView acquisition of Decision point analytics

November 22, 2024November 22, 2024

LatentView Analytics, a leading global digital analytics consulting company, recently completed the acquisition of a 70% stake in Decision Point Analytics. This strategic move aims to enhance LatentView’s capabilities in Revenue Growth Management (RGM) and AI-powered business transformation solutions, particularly within the Consumer Packaged Goods (CPG) sector. Decision Point Analytics,…

Read More
Industry Analysis Comparison of 2 wheeler companies

Comparison of 2 wheeler companies

March 1, 2021June 19, 2022

Also view my analysis on the FMCG players if you like my comparison of 2 wheeler companies.

Read More

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • India’s car industry growth prospects
  • Road length and density by country
  • Comparison of textile yarn companies
  • Go Fashion
  • India consumption story

Subscribe to Math Markets

Loading

Archives

  • March 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • May 2023
  • July 2022
  • June 2022
  • April 2022
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021

Categories

  • Company Analysis
  • Industry Analysis
  • Knowledge Bytes
  • Uncategorized
All the contents published on this blog and other tools offered are the property of Chintan Shah. All rights reserved. The information contained on this website and the resources available for download through this website are for educational and informational purposes only. The stocks discussed in this blog are the research and personal views of the authors should ‘not’ be considered as any kind of buy, sell or any advisory/recommendation.
©2025 Mathmarkets | WordPress Theme by SuperbThemes